Osivax has licensed an influenza…
Osivax has licensed an influenza vaccine from GC Biopharma, positioning [...]
Flagship Pioneering’s ProFound…
Flagship Pioneering’s ProFound Therapeutics is keeping its string of high-profile [...]
Just two months after Someit…
Just two months after Someit Sidhu, M.D., succeeded in pairing [...]
Hansoh Pharmaceutical has given a…
Hansoh Pharmaceutical has given a bullish assessment of China’s innovative [...]
Phase 2 data on Spyre…
Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in [...]
SK Biopharmaceuticals has…
SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 [...]
Having set Metsera on its journey…
Having set Metsera on its journey to a $10 billion [...]
The FDA has extended its review of…
The FDA has extended its review of Capricor Therapeutics’ Duchenne [...]
A new report on the health of the…
A new report on the health of the Massachusetts biotech [...]
TME Pharma’s hunt for a partner…
TME Pharma’s hunt for a partner for its brain cancer [...]